United States Biotechnology & Medical Research

Spring Bank Pharmaceuticals Inc (SBPH)

Track

Ticker: SBPH Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Spring Bank Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Kayitalire Louis
Chief Medical Officer
2 sales — total 437 USD
Planned sale 2 Nov 2021
Value US$4,727,256.50 | Price 327.92 | Shares 29,357
Planned sale 2 Nov 2021
Value US$273,521.93 | Price 361.42 | Shares 12,530
Planned sale 4 Oct 2021
Value US$323,604.29 | Price 204.38 | Shares 20,301
Sale 20 Nov 2020
Value US$833.00 | Price 4.76 | Shares 175
Sale 20 Nov 2020
Value US$833.00 | Price 4.76 | Shares 175
Sale 20 Nov 2020
Value US$833.00 | Price 4.76 | Shares 175
Sale 20 Nov 2020
Value US$833.00 | Price 4.76 | Shares 175
Sale 30 Dec 2019
Value US$50,540.00 | Price 1.26 | Shares 40,000
Buy 14 Nov 2019
Value US$15,200.00 | Price 3.04 | Shares 5,000
Buy 13 Nov 2019
Value US$14,150.00 | Price 2.83 | Shares 5,000
Buy 28 Jun 2019
Value US$49,080.00 | Price 4.09 | Shares 12,000
Buy 29 May 2019
Value US$27,000.00 | Price 5.40 | Shares 5,000
Buy 29 May 2019
Value US$60,300.00 | Price 6.03 | Shares 10,000
Buy 21 May 2019
Value US$33,150.00 | Price 6.63 | Shares 5,000
Buy 30 Apr 2019
Value US$36,800.00 | Price 7.36 | Shares 5,000
Buy 30 Apr 2019
Value US$36,550.00 | Price 7.31 | Shares 5,000
Buy 13 Aug 2018
Value US$48,080.00 | Price 12.02 | Shares 4,000
Buy 28 Feb 2018
Value US$12,830.00 | Price 12.83 | Shares 1,000
Buy 14 Sep 2017
Value US$14,840.00 | Price 14.84 | Shares 1,000
Buy 4 Aug 2017
Value US$28,152.00 | Price 12.24 | Shares 2,300
Buy 4 Aug 2017
Value US$2,450.00 | Price 12.25 | Shares 200
Buy 3 Aug 2017
Value US$12,430.00 | Price 12.43 | Shares 1,000
Buy 3 Aug 2017
Value US$12,280.00 | Price 12.28 | Shares 1,000
Buy 27 Jun 2017
Value US$999,999.00 | Price 13.00 | Shares 76,923
Buy 7 Mar 2017
Value US$18,880.00 | Price 9.44 | Shares 2,000
Buy 23 Feb 2017
Value US$10,515.60 | Price 8.76 | Shares 1,200
Buy 15 Dec 2016
Value US$17,000.00 | Price 8.50 | Shares 2,000
Buy 30 Nov 2016
Value US$15,960.00 | Price 7.98 | Shares 2,000
Buy 9 Nov 2016
Value US$60,830.00 | Price 8.69 | Shares 7,000
Buy 9 Nov 2016
Value US$17,680.00 | Price 8.84 | Shares 2,000
Buy 19 Sep 2016
Value US$16,825.00 | Price 12.50 | Shares 1,346
Buy 16 Sep 2016
Value US$8,125.00 | Price 12.50 | Shares 650
Buy 14 Sep 2016
Value US$6,425.00 | Price 12.50 | Shares 514
Buy 13 Sep 2016
Value US$6,125.00 | Price 12.50 | Shares 490
Buy 9 Sep 2016
Value US$30,000.00 | Price 12.50 | Shares 2,400
Buy 2 Sep 2016
Value US$11,750.00 | Price 11.75 | Shares 1,000
Buy 30 Aug 2016
Value US$12,410.00 | Price 12.41 | Shares 1,000
Buy 24 Aug 2016
Value US$4,200.00 | Price 12.00 | Shares 350
Buy 24 Aug 2016
Value US$1,199.00 | Price 11.99 | Shares 100
Buy 24 Aug 2016
Value US$18,445.00 | Price 11.90 | Shares 1,550
Buy 23 Aug 2016
Value US$32,190.00 | Price 10.73 | Shares 3,000
Buy 23 Aug 2016
Value US$10,740.00 | Price 10.74 | Shares 1,000
Buy 22 Aug 2016
Value US$11,660.00 | Price 11.66 | Shares 1,000
Buy 19 Aug 2016
Value US$11,200.00 | Price 11.20 | Shares 1,000
Buy 16 Aug 2016
Value US$11,370.00 | Price 11.37 | Shares 1,000
Buy 16 Aug 2016
Value US$1,149.00 | Price 11.49 | Shares 100
Buy 15 Aug 2016
Value US$11,200.00 | Price 11.20 | Shares 1,000
Buy 15 Aug 2016
Value US$20,574.00 | Price 11.43 | Shares 1,800
Buy 12 Aug 2016
Value US$29,449.68 | Price 11.33 | Shares 2,600
Buy 9 Aug 2016
Value US$11,110.00 | Price 11.11 | Shares 1,000
Buy 9 Aug 2016
Value US$10,940.00 | Price 10.94 | Shares 1,000
Buy 4 Aug 2016
Value US$10,150.00 | Price 10.15 | Shares 1,000
Buy 4 Aug 2016
Value US$9,770.00 | Price 9.77 | Shares 1,000
Buy 4 Aug 2016
Value US$9,750.00 | Price 9.75 | Shares 1,000
Buy 4 Aug 2016
Value US$9,790.00 | Price 9.79 | Shares 1,000
Buy 11 May 2016
Value US$150,000.00 | Price 12.00 | Shares 12,500
Buy 11 May 2016
Value US$499,992.00 | Price 12.00 | Shares 41,666
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-11-04 2021-11-02 PlS Planned sale
Kayitalire Louis

Chief Medical Officer

Officer
29,357 -28.2%
327.92
US$4,727,257 		29,357 -28.2% 327.92 US$4,727,257
2021-11-04 2021-11-02 PlS Planned sale
Kayitalire Louis

Chief Medical Officer

Officer
12,530 +10.2%
361.42
US$273,522 		12,530 +10.2% 361.42 US$273,522
2021-10-06 2021-10-04 PlS Planned sale
Kayitalire Louis

Chief Medical Officer

Officer
20,301 -0.3%
204.38
US$323,604 		20,301 -0.3% 204.38 US$323,604
2020-11-23 2020-11-20 S Sale
Driscoll Martin J

President and CEO

Executive Director
175 -0.4%
4.76
US$833 		175 -0.4% 4.76 US$833
2020-11-23 2020-11-20 S Sale
2.2
Firmani Lori

VP of Finance and Treasurer

Officer
175 -1.0%
4.76
US$833 		175 -1.0% 4.76 US$833
2020-11-23 2020-11-20 S Sale
1.7
Winslow Garrett

General Counsel and Secretary

Officer
175 -0.9%
4.76
US$833 		175 -0.9% 4.76 US$833
2020-11-23 2020-11-20 S Sale
Iyer Radhakrishnan P.

Chief Scientific Officer

Officer
175 -0.1%
4.76
US$833 		175 -0.1% 4.76 US$833
2020-01-02 2019-12-30 S Sale
Eichler Kurt M
40,000 -6.8%
1.26
US$50,540 		40,000 -6.8% 1.26 US$50,540
2019-11-14 2019-11-14 B Purchase
1.7
Freve Jonathan

CFO & Treasurer
5,000 +40.1%
3.04
US$15,200 		5,000 +40.1% 3.04 US$15,200
2019-11-14 2019-11-13 B Purchase
Driscoll Martin J

President and CEO

Executive Director
5,000 +5.9%
2.83
US$14,150 		5,000 +5.9% 2.83 US$14,150
2019-06-28 2019-06-28 B Purchase
4.1
Smith Scott Andrew
12,000 +637.3%
4.09
US$49,080 		12,000 +637.3% 4.09 US$49,080
2019-05-29 2019-05-29 B Purchase
1.7
Freve Jonathan

CFO & Treasurer
5,000 +66.8%
5.40
US$27,000 		5,000 +66.8% 5.40 US$27,000
2019-05-29 2019-05-29 B Purchase
Driscoll Martin J

President and CEO

Executive Director
10,000 +13.3%
6.03
US$60,300 		10,000 +13.3% 6.03 US$60,300
2019-05-22 2019-05-21 B Purchase
Driscoll Martin J

President and CEO

Executive Director
5,000 +7.1%
6.63
US$33,150 		5,000 +7.1% 6.63 US$33,150
2019-04-30 2019-04-30 B Purchase
Driscoll Martin J

President and CEO

Executive Director
5,000 +7.6%
7.36
US$36,800 		5,000 +7.6% 7.36 US$36,800
2019-04-30 2019-04-30 B Purchase
Driscoll Martin J

President and CEO

Executive Director
5,000 +8.3%
7.31
US$36,550 		5,000 +8.3% 7.31 US$36,550
2018-08-13 2018-08-13 B Purchase Driscoll Martin J

President and CEO

Executive Director
4,000 +7.1%
12.02
US$48,080 		4,000 +7.1% 12.02 US$48,080
2018-03-01 2018-02-28 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +1.8%
12.83
US$12,830 		1,000 +1.8% 12.83 US$12,830
2017-09-14 2017-09-14 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +1.8%
14.84
US$14,840 		1,000 +1.8% 14.84 US$14,840
2017-08-07 2017-08-04 B Purchase Arkowitz David
2,300 +13.5%
12.24
US$28,152 		2,300 +13.5% 12.24 US$28,152
2017-08-07 2017-08-04 B Purchase Arkowitz David
200 +1.2%
12.25
US$2,450 		200 +1.2% 12.25 US$2,450
2017-08-03 2017-08-03 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +1.9%
12.43
US$12,430 		1,000 +1.9% 12.43 US$12,430
2017-08-03 2017-08-03 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +1.9%
12.28
US$12,280 		1,000 +1.9% 12.28 US$12,280
2017-06-27 2017-06-27 B Purchase Eichler Kurt M
76,923 +15.2%
13.00
US$999,999 		76,923 +15.2% 13.00 US$999,999
2017-03-07 2017-03-07 B Purchase Driscoll Martin J

President and CEO

Executive Director
2,000 +4.0%
9.44
US$18,880 		2,000 +4.0% 9.44 US$18,880
2017-02-27 2017-02-23 B Purchase Eichler Kurt M
1,200 +inf%
8.76
US$10,516 		1,200 +inf% 8.76 US$10,516
2016-12-16 2016-12-15 B Purchase Driscoll Martin J

President and CEO

Executive Director
2,000 +4.1%
8.50
US$17,000 		2,000 +4.1% 8.50 US$17,000
2016-12-01 2016-11-30 B Purchase Driscoll Martin J

President and CEO

Executive Director
2,000 +4.3%
7.98
US$15,960 		2,000 +4.3% 7.98 US$15,960
2016-11-10 2016-11-09 B Purchase Eichler Kurt M Non-Executive Director
7,000 +1.6%
8.69
US$60,830 		7,000 +1.6% 8.69 US$60,830
2016-11-10 2016-11-09 B Purchase Driscoll Martin J

President and CEO

Executive Director
2,000 +8.9%
8.84
US$17,680 		2,000 +8.9% 8.84 US$17,680
2016-09-20 2016-09-19 B Purchase Eichler Kurt M Non-Executive Director
1,346 +0.3%
12.50
US$16,825 		1,346 +0.3% 12.50 US$16,825
2016-09-20 2016-09-16 B Purchase Eichler Kurt M Non-Executive Director
650 +0.2%
12.50
US$8,125 		650 +0.2% 12.50 US$8,125
2016-09-15 2016-09-14 B Purchase Eichler Kurt M Non-Executive Director
514 +0.1%
12.50
US$6,425 		514 +0.1% 12.50 US$6,425
2016-09-14 2016-09-13 B Purchase Eichler Kurt M Non-Executive Director
490 +0.1%
12.50
US$6,125 		490 +0.1% 12.50 US$6,125
2016-09-12 2016-09-09 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
2,400 +6.4%
12.50
US$30,000 		2,400 +6.4% 12.50 US$30,000
2016-09-02 2016-09-02 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +4.7%
11.75
US$11,750 		1,000 +4.7% 11.75 US$11,750
2016-08-31 2016-08-30 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +4.9%
12.41
US$12,410 		1,000 +4.9% 12.41 US$12,410
2016-08-24 2016-08-24 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
350 +0.9%
12.00
US$4,200 		350 +0.9% 12.00 US$4,200
2016-08-24 2016-08-24 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
100 +0.3%
11.99
US$1,199 		100 +0.3% 11.99 US$1,199
2016-08-24 2016-08-24 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
1,550 +4.3%
11.90
US$18,445 		1,550 +4.3% 11.90 US$18,445
2016-08-24 2016-08-23 B Purchase Eichler Kurt M Non-Executive Director
3,000 +0.7%
10.73
US$32,190 		3,000 +0.7% 10.73 US$32,190
2016-08-23 2016-08-23 B Purchase Freve Jonathan

CFO, Treasurer & Secretary

Officer
1,000 +100.0%
10.74
US$10,740 		1,000 +100.0% 10.74 US$10,740
2016-08-22 2016-08-22 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +5.1%
11.66
US$11,660 		1,000 +5.1% 11.66 US$11,660
2016-08-22 2016-08-19 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +5.4%
11.20
US$11,200 		1,000 +5.4% 11.20 US$11,200
2016-08-16 2016-08-16 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +5.7%
11.37
US$11,370 		1,000 +5.7% 11.37 US$11,370
2016-08-16 2016-08-16 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
100 +0.3%
11.49
US$1,149 		100 +0.3% 11.49 US$1,149
2016-08-16 2016-08-15 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +6.1%
11.20
US$11,200 		1,000 +6.1% 11.20 US$11,200
2016-08-16 2016-08-15 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
1,800 +5.3%
11.43
US$20,574 		1,800 +5.3% 11.43 US$20,574
2016-08-15 2016-08-12 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
2,600 +8.3%
11.33
US$29,450 		2,600 +8.3% 11.33 US$29,450
2016-08-09 2016-08-09 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +6.5%
11.11
US$11,110 		1,000 +6.5% 11.11 US$11,110
2016-08-09 2016-08-09 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +6.9%
10.94
US$10,940 		1,000 +6.9% 10.94 US$10,940
2016-08-05 2016-08-04 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +7.4%
10.15
US$10,150 		1,000 +7.4% 10.15 US$10,150
2016-08-05 2016-08-04 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +8.0%
9.77
US$9,770 		1,000 +8.0% 9.77 US$9,770
2016-08-05 2016-08-04 B Purchase Freve Jonathan

CFO, Treasurer & Secretary

Officer
1,000 +inf%
9.75
US$9,750 		1,000 +inf% 9.75 US$9,750
2016-08-05 2016-08-04 B Purchase Eichler Kurt M Non-Executive Director
1,000 +0.2%
9.79
US$9,790 		1,000 +0.2% 9.79 US$9,790
2016-05-12 2016-05-11 B Purchase Driscoll Martin J

President and CEO

Executive Director
12,500 +inf%
12.00
US$150,000 		12,500 +inf% 12.00 US$150,000
2016-05-12 2016-05-11 B Purchase Eichler Kurt M Non-Executive Director
41,666 +10.9%
12.00
US$499,992 		41,666 +10.9% 12.00 US$499,992
Explore more

More insider trading research around Spring Bank Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America